HRT Financial’s Compugen CGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-25,163
Closed -$53K 4318
2026
Q1
$53K Buy
+25,163
New +$48.8K ﹤0.01% 3447
2025
Q1
Sell
-20,034
Closed -$30K 2601
2024
Q4
$30K Buy
+20,034
New +$32.6K ﹤0.01% 2158
2024
Q2
Sell
-180,268
Closed -$465K 2314
2024
Q1
$465K Buy
180,268
+164,050
+1,012% +$382K ﹤0.01% 1302
2023
Q4
$32K Buy
+16,218
New +$14.2K ﹤0.01% 1996
2022
Q4
Sell
-25,020
Closed -$16K 2530
2022
Q3
$16K Buy
+25,020
New +$35.3K ﹤0.01% 2500
2022
Q1
Sell
-126,782
Closed -$545K 3175
2021
Q4
$545K Buy
+126,782
New +$686K ﹤0.01% 1685
2021
Q2
Sell
-15,180
Closed -$130K 2918
2021
Q1
$130K Buy
+15,180
New +$168K ﹤0.01% 2415

Other funds holding CGEN

HRT Financial's CGEN Position: Q2 2026 in Review

HRT Financial sold out of Compugen (CGEN) in Q2 2026, closing a stake of 25,163 shares — an estimated $53K sold.

HRT Financial first reported a position in CGEN in Q1 2021 and held it in 7 quarters. The position peaked at $545K in Q4 2021. 82 funds tracked by Wall St. Rank hold CGEN as of Q2 2026.

  • HRT Financial reported no remaining Compugen position as of Q2 2026 after selling out during the quarter.
  • HRT Financial sold 25,163 Compugen shares in Q2 2026, an estimated $53K.
  • HRT Financial first reported a position in Compugen in Q1 2021 and held it in 7 quarters.
  • HRT Financial's Compugen position peaked at $545K in Q4 2021.
  • 82 funds tracked by Wall St. Rank held Compugen as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.